The tumor microenvironment (TME) is not merely a backdrop for cancer development—it’s a dynamic system where cancer cells interact with immune cells, stromal cells, and nutrients to evolve and resist therapy. A key component driving this complexity is lipid metabolism, which has emerged as a crucial regulator of tumor growth, immune response, and therapeutic effectiveness.
At BioTech Support Group, we recognize the critical importance of these lipid-mediated pathways. Our product, Cleanascite™, enhances cancer research by enabling lipid depletion without compromising cellular integrity.
In the TME, lipids go beyond their roles as structural elements or energy reserves—they act as active signaling molecules. Disruptions in lipid metabolism contribute to:
These mechanisms make lipid metabolism a prime target for therapeutic intervention.
Unlike harsh solvent-based lipid extraction methods, Cleanascite™ is a gentle aqueous suspension compatible with sensitive cell-based assays. Cited in over 30 peer-reviewed articles—including those archived in the National Library of Medicine—Cleanascite™ is a trusted solution for lipid removal in cancer research.
Cleanascite™ continues to provide researchers with consistent, high-quality lipid depletion tools across diverse experimental models.
As oncology research advances, Cleanascite™ remains a foundational resource for scientists investigating the intersection of lipid metabolism and cancer biology. Whether it’s uncovering mechanisms of immunosuppression or exploring macrophage dynamics, Cleanascite™ empowers confidence in experimental results.
We invite researchers to delve into the expanding literature featuring Cleanascite™. Contact us to learn how our sample preparation and enrichment technologies can support your research goals.
Lipid metabolism orchestrates how cancer cells grow, survive, and evade immune surveillance. Within the TME, lipids drive cell signaling, immune suppression, and resistance to therapy—making them vital targets for cancer research.
Targeting lipid metabolism can disrupt critical cancer-supporting processes such as inflammation, immune evasion, and therapy resistance. These pathways are emerging as promising targets across a wide range of cancers.
Accumulated lipids in the TME can polarize macrophages into tumor-supportive, immunosuppressive states. Studying these effects helps researchers find ways to reprogram TAMs and enhance anti-tumor immunity.
